Legal & General Group
RAPT

Legal & General Group’s RAPT Therapeutics RAPT Stock Holding History

Legal & General Group’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-297
Closed -$2.9K – 3515
2025
Q1 		$2.9K Hold
297
– – ﹤0.01% 3330
2024
Q4 		$3.76K Hold
297
– – ﹤0.01% 3360
2024
Q3 		$4.78K Hold
297
– – ﹤0.01% 3372
2024
Q2 		$7.23K Sell
297
-1,718
-85% -$79.4K ﹤0.01% 3348
2024
Q1 		$145K Sell
2,015
-606
-23% -$84.3K ﹤0.01% 2714
2023
Q4 		$521K Sell
2,621
-10
-0.4% -$1.24K ﹤0.01% 2434
2023
Q3 		$350K Buy
2,631
+152
+6% +$24.8K ﹤0.01% 2569
2023
Q2 		$371K Buy
2,479
+951
+62% +$148K ﹤0.01% 2557
2023
Q1 		$224K Buy
1,528
+243
+19% +$49.1K ﹤0.01% 2551
2022
Q4 		$204K Buy
1,285
+159
+14% +$25.4K ﹤0.01% 2601
2022
Q3 		$217K Buy
1,126
+68
+6% +$12.9K ﹤0.01% 2592
2022
Q2 		$155K Buy
1,058
+172
+19% +$22.9K ﹤0.01% 2726
2022
Q1 		$156K Sell
886
-3
-0.3% -$567 ﹤0.01% 2754
2021
Q4 		$261K Buy
889
+6
+0.7% +$1.6K ﹤0.01% 2607
2021
Q3 		$220K Buy
883
+502
+132% +$133K ﹤0.01% 2655
2021
Q2 		$96K Buy
381
+82
+27% +$15.3K ﹤0.01% 2753
2021
Q1 		$53K Buy
299
+132
+79% +$21.8K ﹤0.01% 2799
2020
Q4 		$26K Hold
167
– – ﹤0.01% 2992
2020
Q3 		$43K Sell
167
-59
-26% -$13.1K ﹤0.01% 2748
2020
Q2 		$52K Buy
226
+193
+585% +$29.8K ﹤0.01% 2720
2020
Q1 		$5K Hold
33
– – ﹤0.01% 3268
2019
Q4 		$7K Buy
+33
New +$6.08K ﹤0.01% 3324

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Legal & General Group's RAPT Position: Q2 2025 in Review

Legal & General Group sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 297 shares — an estimated $2.9K sold.

Legal & General Group first reported a position in RAPT in Q4 2019 and held it in 22 quarters. The position peaked at $521K in Q4 2023. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

  • Legal & General Group reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 297 RAPT Therapeutics shares in Q2 2025, an estimated $2.9K.
  • Legal & General Group first reported a position in RAPT Therapeutics in Q4 2019 and held it in 22 quarters.
  • Legal & General Group's RAPT Therapeutics position peaked at $521K in Q4 2023.
  • 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.